NVR BCR Pill - red capsule/oblong, 22mm

Generic Name: nilotinib

Pill with imprint NVR BCR is Red, Capsule/Oblong and has been identified as Tasigna 150 mg. It is supplied by Novartis Pharmaceuticals.

Tasigna is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR BCR

Tasigna

Generic Name: nilotinib
Imprint: NVR BCR
Strength: 150 mg
Color: Red
Size: 22.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Novartis Pharmaceuticals
National Drug Code (NDC): 00078-0592
Inactive Ingredients: silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, poloxamer 188, gelatin, ferric oxide red, ferric oxide yellow, titanium dioxide
Note: Inactive ingredients may vary.